VEGFA and neoplasm: VEGF can be a predictor of tumor recurrence and can be used as a good biomarker for disease progression or remission during gastric cancer surveillance, but it cannot be used as an independent clinical diagnostic factor, and can only play an auxiliary diagnostic role [77].